Reported Tuberculosis in the United States, 2017

Related Pages

Return to Main Menu

Table 16. National Tuberculosis Genotyping Surveillance Coverage1 : United States, 2004-2017

Table 16. National Tuberculosis Genotyping Surveillance Coverage: United States, 2004-2017
Year Reported TB Cases Reported Culture-Positive Cases Cases with Genotype Results Genotype Surveillance Coverage
No. No. No. (%)
2004 14,499 11,327 5,954 52.6
2005 14,065 10,957 7,500 68.4
2006 13,727 10,744 7,528 70.1
2007 13,280 10,425 8,428 80.8
2008 12,889 10,020 8,177 81.6
2009 11,514 8,880 7,715 86.9
2010 11,100 8,412 7,704 91.6
2011 10,504 8,084 7,617 94.2
2012 9,935 7,626 7,235 94.9
2013 9,561 7,368 7,063 95.9
2014 9,398 7,232 6,991 96.7
2015 9,547 7,418 7,206 97.1
2016 9,253 7,171 6,986 97.4
2017 9,105 7,111 6,851 96.3

1 Genotype surveillance coverage is defined as the percentage of all culture positive tuberculosis (TB) cases for which there was a genotyped isolate.
Note: This table reflects genotyping surveillance coverage for the 50 states and the District of Columbia; for genotyping surveillance coverage of the U.S.-affiliated areas, please see Table 17.

Page last reviewed: October 22, 2018
Content source: Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention